Financial Statements — IBTA
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Cash & Equivalents | 148.17 | 164.60 | 223.30 | 250.55 | 297.13 | 341.27 | 317.86 | 79.50 |
| Accounts Receivable | 203.39 | 183.05 | 212.82 | 208.98 | 206.16 | 227.79 | 209.02 | 206.43 |
| Total Current Assets | 365.64 | 361.00 | 455.46 | 482.65 | 527.99 | 576.06 | 534.23 | 300.14 |
| Property, Plant & Equipment | 23.20 | 23.21 | 19.58 | 9.04 | 4.44 | 2.06 | 2.27 | 2.38 |
| Total Non-current Assets* | 119.76 | 118.92 | 113.97 | 118.13 | 111.28 | 22.21 | 21.82 | 21.93 |
| Total Assets | 485.40 | 479.92 | 569.43 | 600.78 | 639.26 | 598.27 | 556.05 | 322.07 |
| Accounts Payable | 7.31 | 7.24 | 15.31 | 10.60 | 11.30 | 8.25 | 5.24 | 7.68 |
| Total Current Liabilities | 213.47 | 200.92 | 206.53 | 204.03 | 196.50 | 211.47 | 190.17 | 181.67 |
| Long-term Debt | -- | -- | -- | -- | -- | 0.00 | 0.00 | 65.27 |
| Total Non-current Liabilities* | 30.36 | 30.02 | 33.30 | 42.62 | 41.48 | 8.84 | 6.18 | 96.31 |
| Total Liabilities | 243.83 | 230.94 | 239.83 | 246.65 | 237.99 | 220.31 | 196.35 | 277.97 |
| Retained Earnings | (148.42) | (147.19) | (135.87) | (137.40) | (139.89) | (216.62) | (233.86) | (199.89) |
| Total Stockholder Equity | 241.57 | 248.98 | 329.61 | 354.13 | 401.28 | 377.96 | 359.70 | 44.10 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Total Revenue | 88.91 | 82.48 | 88.53 | 83.26 | 86.03 | 84.57 | 98.38 | 98.62 | 87.93 | 82.33 |
| Cost of Revenue | 19.19 | 19.45 | 18.90 | 17.14 | 17.93 | 17.09 | 15.15 | 12.17 | 12.28 | 10.52 |
| Gross Profit | 69.72 | 63.03 | 69.63 | 66.12 | 68.10 | 67.48 | 83.23 | 86.45 | 75.64 | 71.81 |
| Research & Development | 15.07 | 14.50 | 14.25 | 14.02 | 14.75 | 18.07 | 15.82 | 16.29 | 17.53 | 13.64 |
| Selling, General & Admin | 21.79 | 23.76 | 22.13 | 22.47 | 22.26 | 21.39 | 20.25 | 20.63 | 28.71 | 13.15 |
| Total Operating Expenses | 71.60 | 73.86 | 71.27 | 63.75 | 66.87 | 70.29 | 70.26 | 65.74 | 97.30 | 55.91 |
| Operating Income | (1.88) | (10.83) | (1.64) | 2.37 | 1.24 | (2.80) | 12.97 | 20.71 | (21.66) | 15.91 |
| Pretax Income | (0.53) | (9.35) | 0.24 | 5.25 | 3.87 | 0.48 | 17.00 | 25.13 | (30.03) | 12.40 |
| Tax Provision | 0.70 | 0.97 | 1.25 | 3.72 | 1.38 | (0.07) | (59.17) | 7.89 | 3.94 | 3.10 |
| Net Income | (1.23) | (10.32) | (1.00) | 1.53 | 2.49 | 0.56 | 76.17 | 17.24 | (33.97) | 9.30 |
| Basic EPS | (0.05) | (0.43) | (0.03) | 0.05 | 0.09 | 0.02 | 2.61 | 0.56 | (1.32) | 1.00 |
| Diluted EPS | (0.05) | (0.43) | (0.03) | 0.05 | 0.08 | 0.02 | 3.04 | 0.51 | (1.32) | 0.33 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Operating Cash Flow | 13.26 | 30.37 | 27.81 | 21.75 | 25.86 | 19.86 | 21.99 | 39.54 | 35.02 | 19.37 |
| Capital Expenditures | 0.89 | 3.07 | 7.53 | 7.25 | 3.63 | 1.89 | 0.22 | 0.30 | 0.20 | 0.15 |
| Free Cash Flow* | 12.37 | 27.31 | 20.28 | 14.51 | 22.23 | 17.97 | 21.77 | 39.24 | 34.82 | 19.21 |
| Investing Cash Flow | (5.20) | (7.06) | (11.17) | (11.16) | (7.00) | (4.97) | (2.54) | (2.87) | (2.32) | (2.47) |
| Financing Cash Flow | (24.48) | (45.33) | (53.37) | (37.85) | (65.78) | (67.05) | (11.03) | (13.26) | 205.66 | 0.01 |
* Derived from reported values